References
Bentas W, Beecken WD, Glienke W, Binder J, Schuldes H (2003) Serum levels of basic fibroblast growth factor reflect disseminated disease in patients with testicular germ cell tumors. Urol Res 30:390
Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ (1998) Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77:956
Werther K, Christensen IJ, Nielsen HJ (2002) Determination of vascular endothelial growth factor (VEGF) in circulating blood: significance of VEGF in various leucocytes and platelets. Scand J Clin Lab Invest 62:343
Hormbrey E, Gillespie P, Turner K, Han C, Roberts A, McGrouther D, Harris AL (2002) A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clin Exp Metastasis 19:651
Pinedo HM, Verheul HM, D’Amato RJ, Folkman J (1998) Involvement of platelets in tumour angiogenesis? Lancet 352:1775
Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 94:395
Dittadi R, Meo S, Fabris F, Gasparini G, Contri D, Medici M, Gion M (2001) Validation of blood collection procedures for the determination of circulating vascular endothelial growth factor (VEGF) in different blood compartments. Int J Biol Markers 16:87
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferrero, S. Angiogenic factors in serum of patients with testicular germ cell tumours. Urol Res 32, 248 (2004). https://doi.org/10.1007/s00240-004-0433-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-004-0433-7